BioSpace News Archive

After nearly a month in limbo, AstraZeneca will resume Phase III testing of its COVID-19 vaccine candidate in the United States.

Iterum Therapeutics plc announced the pricing of a public offering of 26,923,076 ordinary shares, together with warrants to purchase up to 20,192,307 ordinary shares at a combined effective price to the public of $0.65 per ordinary share and associated warrant.

According to Transparency Market Research’s latest report on the global medical imaging equipment services market for the historical period 2017–2018 and forecast period 2019–2027, Hospital centric business model favoring long term partnerships is projected to drive the global medical imaging equipment services market during the forecast period

Rheumatoid arthritis is an inflammatory disease of the body’s supportive tissues, usually affecting an individual’s toes and fingers.

Laparoscopy is a surgical technique that is utilized to enter into body cavities with minimal external cuts and intrusions.

Ischemia reperfusion (IR) injury occurs when blood supply, perfusion, and concomitant reoxygenation is restored to an organ or area following an initial poor blood supply after a critical time period.

Hereditary testing is usually referred to as genetic testing or DNA testing. Hereditary testing is employed to spot alterations in the DNA sequence that correlate with a disease or higher risk to develop a disease.

The global foot and mouth disease vaccines market is foreseen to attain growth as vaccination is considered to be a basic yet important initiative undertaken to curb animal loss.

According to Transparency Market Research’s latest report on the global extracorporeal membrane oxygenation machine market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence and incidence of respiratory and cardiovascular diseases to escalate the growth of global extracorporeal membrane oxygenation machine market.

According to Transparency Market Research’s latest report on the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of cystic fibrosis and chronic pancreatitis to escalate the growth of global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market.